NeuroBo Pharmaceuticals, Inc.(NASDAQ:NRBO) 
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with mode...
Website: http://www.neurobopharma.com
Founded: 2017
CEO: Richard Kang
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-22
P
O 3.71
H 3.83
L 3.57
C 3.67
V 14,406
10EMA 3.67
20EMA 3.67
60EMA 3.67
120EMA 3.67
250EMA 3.67